Senior equity research analyst since 1998 with extensive experience in healthcare across service and product sectors. Five-time recipient of Wall Street Journal's Annual Best on the Street award and 5-time Starmine Analyst Award winner. Success driven by deep analytical curiosity, disciplined evaluation of both macro and micro factors, willingness to be patient yet act quickly when warranted, and perseverance through periods of irrationality. I employ a variety of valuation methodologies, which drive and validate the investment analysis and recommendations. These include discounted cash flow, EV/EBITDA, discounted earnings, price/earnings, and dividend and free cash flow yield analyses.Specialties: Investment analysis - healthcare, all capitalizations-Managed Care-Healthcare information technology-Pharmaceutical servicesMarket research, Competitive intelligence, and SWOT analysisM&A analysis, capital structure analysis, and support of securities offeringsWell-traveled through spreadsheets and adept at developing insightful reports and presentations of industry analysis and investment recommendations.